3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Multiple Myeloma
8
Pancreatic Neoplasms
7
Neoplasms
6
Neoplasms, Plasma Cell
4
Myelodysplastic Syndromes
4
Colorectal Neoplasms
3
Stomatitis
2
Skin Neoplasms
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Myeloproliferative Disorders
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Inflammation
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Sarcoma
1
Recurrence
1
Primary Myelofibrosis
1
Myofibroma
1
Myelodysplastic-Myeloproliferative Diseases
1
Multiple Endocrine Neoplasia Type 1
1
Mucositis
1
Motor Activity
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Limb-girdle muscular dystrophy, type 2C
1
Interventions
Aspirin
4
Blood Pressure
3
Vitamin E
2
Vitamin D
2
Nutrition Assessment
2
Metformin
2
Geritol
2
Diet, Mediterranean
2
Cholecalciferol
2
phosphoribosylformylglycinamidine synthetase
1
glycidol
1
ficlatuzumab
1
beta Carotene
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Vorinostat
1
Vascular Stiffness
1
Tumor Necrosis Factor Inhibitors
1
Therapeutics
1
Sugars
1
Spironolactone
1
Resistance Training
1
Raloxifene Hydrochloride
1
Pulse Wave Analysis
1
Progestins
1
Physical Conditioning, Human
1
Omeprazole
1
Noninvasive Prenatal Testing
1
Naproxen
1
Methods
1
Lysine Acetyltransferase 5
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Cardiovascular Diseases
×
Ascorbic Acid
×
Clear all
NCT00270647
2018-02-28
PHS II
Brigham and Women's Hospital
Phase NA
Completed
14,641 enrolled